144 related articles for article (PubMed ID: 22612020)
1. [Gene tests in cardiac rhythm disturbances--new international expert recommendations].
Swan H
Duodecim; 2012; 128(7):697-704. PubMed ID: 22612020
[TBL] [Abstract][Full Text] [Related]
2. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
Maron BJ; Moller JH; Seidman CE; Vincent GM; Dietz HC; Moss AJ; Sondheimer HM; Pyeritz RE; McGee G; Epstein AE
Circulation; 1998 Oct; 98(14):1460-71. PubMed ID: 9841131
[No Abstract] [Full Text] [Related]
3. AHA assesses the impact of genotyping on diagnosis of genetic cardiac disease. American Heart Association.
Morey SS
Am Fam Physician; 1999 May; 59(10):2915-6, 2918. PubMed ID: 10348078
[No Abstract] [Full Text] [Related]
4. Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome.
Vincent GM
Heart; 2001 Jul; 86(1):12-4. PubMed ID: 11410552
[No Abstract] [Full Text] [Related]
5. Genetic testing for inherited cardiac arrhythmias.
Fowler SJ; Cerrone M; Napolitano C; Priori SG
Hellenic J Cardiol; 2010; 51(2):92-103. PubMed ID: 20378510
[No Abstract] [Full Text] [Related]
6. The role of genetic testing in paediatric syndromes of sudden death: state of the art and future considerations.
McCormack J
Cardiol Young; 2009 Nov; 19 Suppl 2():54-65. PubMed ID: 19857351
[No Abstract] [Full Text] [Related]
7. Use and interpretation of genetic tests in cardiovascular genetics.
Caleshu C; Day S; Rehm HL; Baxter S
Heart; 2010 Oct; 96(20):1669-75. PubMed ID: 20937756
[No Abstract] [Full Text] [Related]
8. The long QT syndrome and catecholaminergic polymorphic ventricular tachycardia.
Monteforte N; Priori SG
Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S52-7. PubMed ID: 19602163
[TBL] [Abstract][Full Text] [Related]
9. Long QT syndrome genotyping by electrocardiography: fact, fiction, or something in between?
Kanters JK; Graff C; Andersen MP; Hardahl T; Toft E; Christiansen M; Bloch Thomsen PE; Struijk JJ
J Electrocardiol; 2006 Oct; 39(4 Suppl):S119-22. PubMed ID: 16920146
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary risk of sudden cardiac death--genetic investigation of the family].
Lundin C; Platonov P; Kristoffersson U
Lakartidningen; 2009 Apr 7-21; 106(15-16):1089-93. PubMed ID: 19492675
[No Abstract] [Full Text] [Related]
11. The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.
Burn J; Camm J; Davies MJ; Peltonen L; Schwartz PJ; Watkins H
Heart; 1997 Aug; 78(2):110-6. PubMed ID: 9326982
[No Abstract] [Full Text] [Related]
12. [Clinical relevance of genetic testing in hypertrophic cardiomyopathy].
Girolami F; Bardi S; Berti L; Cecchi F; Servettini E; Tomberli B; Torricelli F; Olivotto I
Recenti Prog Med; 2011 Dec; 102(12):486-93. PubMed ID: 22258194
[TBL] [Abstract][Full Text] [Related]
13. Congenital long QT syndromes: clinical features, molecular genetics and genetic testing.
Ching CK; Tan EC
Expert Rev Mol Diagn; 2006 May; 6(3):365-74. PubMed ID: 16706739
[TBL] [Abstract][Full Text] [Related]
14. [Genetic testing of patients with cardiomyopathies, the resuscitated and victims of sudden death--new international expert recommendations].
Swan H
Duodecim; 2012; 128(9):937-44. PubMed ID: 22667046
[TBL] [Abstract][Full Text] [Related]
15. [Genetics of hereditary cardiopathies].
Debrus S; de Meeus A; Jean MK; Bouvagnet P
Arch Mal Coeur Vaiss; 1996 May; 89(5):619-27. PubMed ID: 8758572
[TBL] [Abstract][Full Text] [Related]
16. Familial hypertrophic cardiomyopathy associated with prolongation of the QT interval.
Peters S; Rust H; Trümmel M; Brattström A
Z Kardiol; 2000 Jul; 89(7):624-9. PubMed ID: 10957789
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.
Bos JM; Towbin JA; Ackerman MJ
J Am Coll Cardiol; 2009 Jul; 54(3):201-11. PubMed ID: 19589432
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing for long QT syndrome.
Technol Eval Cent Assess Program Exec Summ; 2008 Feb; 22(9):1-5. PubMed ID: 18411500
[No Abstract] [Full Text] [Related]
19. Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?
Ackerman MJ
Curr Opin Cardiol; 2005 May; 20(3):175-81. PubMed ID: 15861004
[TBL] [Abstract][Full Text] [Related]
20. Can genetic testing improve our aim in hypertrophic cardiomyopathy?
Charitakis K; Basson CT
Circ Res; 2010 May; 106(9):1446-8. PubMed ID: 20466986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
